About
Quantum Intelligence Corp (QIC) integrates quantum computing with artificial intelligence to support drug discovery. Its QUEST platform uses algorithms that analyze how electronic charges are distributed in molecules to predict drug behavior, effectiveness, and safety, relying on an artificial neural network prediction model that adopts the 3D distribution of electrostatic potentials (ESPs) derived from quantum mechanics. In August 2024, QIC partnered with QuEra Computing to use quantum computers to improve QUEST platform performance. The company also collaborates with Oxford Quantum Circuits in the UK, Quandela in France, and Classiq in Israel, and runs a joint venture with 48Hour Discovery in Canada. Beyond healthcare, QIC explores quantum computing for finance, including algorithmic trading, risk analysis, and asset management.
Quantum Specifications
| Quantum Focus | software |